Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


       2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

healthy capsules

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Diltiazem Hcl Manufacturers in India Suppliers Diltiazem Hcl Dossage Exporters Distributors Diltiazem Hcl api active pharmaceuticals ingredients Diltiazem Hcl manufacturers Side Effects bulk drugs raw material Dossage Diltiazem Hcl companies Side Effects Dossage Importers Diltiazem Hcl Dossage Diltiazem Hcl Exporters Diltiazem Hcl exporters Dossage FDA Dossage Diltiazem Hcl Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Diltiazem Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Diltiazem Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Diltiazem Hydrochloride active pharmaceutical ingredients Diltiazem Hydrochloride committee active pharmaceutical ingredients manufacturer Diltiazem Hydrochloride Active Pharmaceutical Ingredients manufacturer Diltiazem Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Diltiazem Hcl, Diltiazem Hcl manufacturer India, Diltiazem Hcl product, Diltiazem Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Diltiazem Hcl anti ulcer product, Certificate of Origin COA Diltiazem Hcl COS Diltiazem Hcl, pharmaceutical generic, pharmaceutical drug, medical, Diltiazem Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Diltiazem Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Diltiazem Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Diltiazem Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Diltiazem Hcl ingredients, api, HIV Diltiazem Hcl, tablets, capsules, syrup & protein Diltiazem Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Diltiazem Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Diltiazem Hcl WHO, UKMHRA Approval

 
   PRODUCT LIST
   Home
   API
   Pharmaceuticals API List >>>
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 
   
tablets4

stright capsules

 

 






 






 

 

 

 
HOME >> Pharmaceuticals API List 1 >> Diltiazem Hcl >> Dosage

Diltiazem  Hcl  CAS No75472-91-2
DOSAGE
Diltiazem Hcl
CAS No : 75472-91-2
 
  
This page explains that the starting diltiazem dosage for treating high blood pressure or chest pain will be based on several factors. This page explores these factors and lists dosing guidelines for extended-release and short-acting diltiazem

 

  • Medication should never be administered without first consulting your veterinarian.
     
  • The typical dose administered to dogs is 0.25 to 0.5 mg per pound (0.5 to 1.0 mg/kg) every eight hours, but the dose is quite variable depending on the response and underlying medical condition.
     
  • The typical dose administered to cats is 7.5 mg per cat three times daily.
     
  • Frequently diltiazem is given with other drugs, especially in pets undergoing treatment for heart failure or arrhythmias (abnormal heart rhythm). In these situations, a lower initial dose may be prescribed to allow the pet time to adjust to the new medication.
  • Hypertension: Dosage needs to be adjusted by titration to individual patient needs. When used as monotherapy, usual starting doses are 120 to 240 mg once daily. Maximum antihypertensive effect is usually observed by 14 days of chronic therapy; therefore, dosage adjustments should be scheduled accordingly. The usual dosage range studied in clinical trials was 120 to 540 mg once daily. Current clinical experience with 540 mg dose is limited; however, the dose may be increased to 540 mg once daily.

  • f overdose is suspected, contact your local poison control center or emergency room immediately.
  • Symptoms of overdose may include dizziness, weakness, slowed or irregular heartbeat, nausea, drowsiness, confusion, and slurred speech.
  • Missed Dose

    If you miss a dose, take as soon as remembered; do not take if it is almost time for the next dose, instead, skip the missed dose and resume your usual dosing schedule.


     Do not "double-up the dose to catch up.

    Information Associated with Product :  

    Dosage >>
    Uses
    Side Effects
    Pharmacology


                              
    PDF DOWNLOAD     WORD DOCUMENT 

    Product Enquiry Product Quotation Sample Request Place Your Order  
    Product Enquiry Product Quotation Sample Request Place Your Order  
    Taj pharmaceuticals API Logo

    Diltiazem HCl

    More Api at Taj Pharmaceuticals Ltd.

    Alfuzosin

    Oseltamivir Phosphate

     Amlodipine Besylate

    Aripiprazole

    Atorvastatin Calcium

    Candesartan Cilaxetil

    Cefdinir

    Cetirizine Dihydrochloride

    Ciprofloxacin HCl

    Dextromethorphan Base

    Diltiazem HCl

    Domperidone Base

    Domperidone Maleate

    Doxazosin Mesylate

     Duloxetine HCl

    Dutasteride

    Enalapril Maleate

    Esomeprazole Magnesium

    Famotidine

    Fexofenadine HCl

    Fluconazole

    Fluoxetine HCl

    Galantamine HBr

    Ibuprofen

    Caffeine

    Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

    Investor Relations    Feedback     Contact Worldwide    Sitemap
     

    taj group logo
    2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
    Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals  Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals  Ltd product or are experiencing a medical emergency, please consult your health care provider.
    Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.